Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda

Sexually Transmitted Infections

Volumn 84, Issue 4, 2008, Pages 306-311

  Safaeian, Mahboobeh ^a,f   Kiddugavu, M ^b   Gravitt, P E ^a   Gange, S J ^a   Ssekasanvu, J ^b   Murokora, D ^b   Sklar, M ^c   Serwadda, D ^b,d   Wawer, M J ^e   Shah, K V ^e   Gray, R ^e  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^c Columbia University ^*  (United States)

^d MAKERERE UNIVERSITY   (Uganda)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANDIDIASIS; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEALTH SURVEY; HERPES ZOSTER; HUMAN; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; RISK; RISK FACTOR; SELF REPORT; SEXUALITY; STATISTICAL SIGNIFICANCE; TUBERCULOSIS; TUMOR VIRUS; UGANDA; VAGINA; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS; RURAL HEALTH; TUMOR VIRUS INFECTIONS; UGANDA;

EID: 49049114278     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2007.027318     Document Type: Article

References (24)

1. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
2. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348:518-27.
3. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
4. Vizcaino AP, Moreno V, Bosch FX, et al. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma, Int J Cancer 2000;86:429-35.
5. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37(Suppl 8):S4-66.
6. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
7. Safaeian NI, Kiddugavu M, Gravitt PE, et al. Comparability of self-collected vaginal swabs and physician-collected cervical swabs for detection of human papillomavirus infections in Rakai, Uganda. Sex Transm Dis 2007;34:429-36.
8. Wawer MJ, Gray RH, Sewankambo NK, et al. A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS 1998;12:1211-25.
9. Gravitt PE, Peyton CL, Apple RJ, et al. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998;36:3020-7.
10. Gravitt PE, Lacey JV Jr, Brinton LA, et al. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev 2001;10:95-100.
11. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000;38:357-61.
12. Schiffman M, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 2000;283:87-93.
13. Peyton CL, Schiffman M, Lorincz AT, et al. Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol 1998;36:3248-54.
14. Terry G, Ho L, Londesborough P, et al. Detection of high-risk HPV types by the hybrid capture 2 test. J Med Virol 2001;65:155-62.
15. Castle PE, Schiffman M, Burk RD, et al. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol Biomarkers Prev 2002;11:1394-9.
16. Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005;366:991-8.
17. Castle PE, Schiffman M, Bratti MC, et al. A population-based study of vaginal human papillomavirus infection in hysterectomized women. J Infect Dis 2004;190:458-67.
18. Castle PE, Schiffman M, Glass AG, et al. Human papillomavirus prevalence in women who have and have not undergone hysterectomies. J Infect Dis 2006;194:1702-5.
19. Castle PE, Jeronimo J, Schiffman M, et al. Age-related changes of the cervix influence human papillomavirus type distribution. Cancer Res 2006; 66:1218-24.
20. UNAIDS. 2006 AIDS Epidemic Update. UNAIDS. 2006. http://data.unaids.org/pub/EpiReport/2006/04- sub_Saharan_Africa_2006_EpiUpdate_eng.pdf (accessed 30 March 2008).
21. . Palefsky JM. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr Opin Oncol 2003;15:382-8.
22. Sun XW, Ellerbrock TV, Lungu O, et al. Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstet Gynecol 1995;85(5 Pt 1):680-6.
23. Winer RL, Hughes JP, Feng Q, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006;354:2645-54.
24. Jamieson DJ, Duerr A, Burk R, et al. Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. Am J Obstet Gynecol 2002;186:21-7.